Latest ArticlesCChronic obstructive pulmonary disease(COPD) could be categorized as lung distension, cough and wheezing in traditional Chinese medicine, the course of the disease is prolonged and prone to recurrent episodes, which seriously affects the quality of patients' survival. The mechanism of this disease is based on ''disordered Qi, phlegm and stasis obstructing the channels'', accompanied by deficiency of viscera and internal organs, Qi and blood injury, phlegm and blood stasis, and other pathogenic factors in the collaterals, and acute exacerbations are provoked by exposure to external pathogenic factors. Accordingly, it is classified into the four directions of regulating activities of Qi, regulating and invigorating Qi, promoting blood circulation and resolve phlegm to dredge collaterals, promoting Qi and blood circulation to dredge collaterals, to improve airway remodeling by regulating Qi and blood flow and power, removing pathological products and repairing damaged tissue cells. This article discussed the treatment of COPD from the method of regulating Qi and collaterals, interpreted from the perspective of improving airway remodeling and analyzed a clinical case to expand the therapeutic ideas for the clinic.
Interleukin(IL)-32 is an important pro-inflammatory cytokine that is widely expressed in normal tissues.In various respiratory diseases, the expression level of IL-32 is significantly upregulated and plays an important role in the occurrence and development of the disease, which may serve as a biomarker for disease prognosis. Furthermore, elucidating its the biological functions and mechanisms may provide a foundation for developing IL-32-targeted therapies. This paper reviewed biological activity of IL-32 and its research progress in respiratory diseases such as chronic obstructive pulmonary disease, asthma, and pulmonary tuberculosis, to provide theoretical basis for clinical diagnosis, treatment, and prognosis of respiratory diseases.
Melanotransferrin(CD228) is a carboxy-terminal glycosyl-phosphatidylinositol anchored glycoprotein that plays a role in cell proliferation and tumorigenesis, angiogenesis, and iron transport and metabolism. Due to its heterogeneous expression in tumor cells, especially melanoma, and low expression in normal cells, CD228 is generally considered to be a specific target of antibody-drug conjugate(ADC). It is expected to provide a new treatment option for patients with advanced metastatic melanoma. This paper systematically reviewed the function of CD228, the basic principle of CD228 as an ADC target and its killing mechanism on tumors, the ADC drugs and their clinical application prospects of CD228 targeted therapy for melanoma, aiming to provide references for the development of CD228 targeted melanoma drugs.
The clinical use of targeted agents has revolutionized treatment strategies for non-small cell lung cancer(NSCLC) patients carrying targetable mutations for two decades, and has resulted in significant survival benefits. In recent years, the types and clinical use of targeted agents have expanded, with breakthroughs in the treatment of advanced to locally advanced unresectable patients and perioperative adjuvant treatment of resectable patients. In advanced patients, the combination of targeted drugs with chemotherapy or dual-antibody drugs has also provided new options for first-line and subsequent treatment. Meanwhile, antibody-drug conjugates have made positive progress in the subsequent treatment of advanced patients. This article aimed to review the research progress of targeted drugs in the clinical application of intermediate and advanced NSCLC.
Non-alcoholic steatohepatitis(NASH), as a chronic metabolic disease, is closely related to obesity, diabetes mellitus type 2, hyperlipidemia and other metabolic syndromes. Its pathogenesis involves multiple factors such as genetics, environment and lifestyle, especially metabolic disorders as the core driving force, which promote disease progression through oxidative stress, endoplasmic reticulum stress and inflammatory pathway activation. For the treatment of NASH, multiple potential therapeutic targets have been identified, such as metabolic regulation, blocking of inflammatory pathways, and anti-fibrosis. NASH may also progress to severe diseases such as cirrhosis and liver cancer, which poses a major threat to human health. In addition, NASH is often accompanied by other metabolic diseases, forming a vicious cycle that further increases the difficulty of treatment and the burden on patients. This article aims to comprehensively review the pathogenesis, therapeutic targets and drug research progress of NASH, and discuss its harm to humans, so as to provide reference for future research and clinical practice.
Metabolic associated steatohepatitis(MASH), formerly known as non-alcoholic steatohepatitis. If the disease is not controlled, it can lead to cirrhosis and liver cancer. With the continuous development of the discipline, the diagnosis and treatment of MASH have made great progress. However, because of its complex mechanism of action, many clinical trials have failed even after entering phase Ⅲ. This aritcle focused on the metabolic disorder of MASH, and summarized the double/triple receptor agonists targeting the metabolism of glucagon peptide-1 receptor and other incretin signaling pathways, so as to provide certain references for the better development of MASH treatment and the design of related clinical trials.
Fatty liver is a disease characterized by abnormal accumulation of fat in liver cells, the incidence of which is increasing year by year, and has become an urgent public health problem in the world. The pathogenesis of fatty liver is complex, including alcoholic and non-alcoholic factors, metabolic disorders and drug effects. In recent years, traditional Chinese medicine and its active ingredients have been widely concerned by researchers because of their unique multi-target characteristics and overall conditioning effects. This article reviewed the research progress of some Chinese herbal compounds and their effective components in the treatment of non-alcoholic fatty liver disease.
To investigate the effects of lipopolysaccharide(LPS) on organoid growth, stem cells and related pathways.
The intestinal crypts of C57BL/6J mice were aseptically isolated and collected in vitro, and the three-dimensional small intestinal organoids with multi-bud structure were cultured. Immunofluorescence staining was used to identify the cell composition of small intestinal organoids. After passage, small intestinal organoids were randomly divided into control group(LPS 0 μg/ml) and different concentrations of LPS groups(30、100 and 300 μg/ml). The growth and morphological characteristics of organoids, and the changes of stem cells and proliferating cells induced by LPS were observed. Comparative RNA sequencing and bioinformatics analysis were used to characterize the changes in genes and pathways induced by LPS.
In D6 culture, small intestinal crypts formed stereoscopic intestinal organoids with multiple budding structures accompanying the intestinal lumen. After modeling, LPS inhibited the formation of intestinal organoid sprout structure, and the area of intestinal organoids was significantly reduced in a dose-dependent manner. IF staining results showed that the expression of intestinal cells and proliferating cells was increased. The comparative RNA sequencing showed that the expression of stem cells and proliferation-related genes was significantly increased, and the stem cells pathway was enriched.
The LPS-induced intestinal organoid injury model was initially constructed in vitro, and the mechanism and pathway of stem cell enhancement after injury were revealed, providing a reliable research platform for the mechanism research of intestinal diseases and the screening of effective drugs.
To investigate the function and mechanism of trigonelline on radicular pain in rat model of lumbar disc herniation(LDH).
The LDH rat model was established by autologous nucleus pulposus transplantation. Western blot was used to detect the expression levels of ionized calcium-binding adapter protein(Iba)-1 in microglia and glial fibrillary acidic protein(GFAP) and Toll-like receptor(TLR)4/NOD-like receptor protein(NLRP)3 related pathway proteins in astrocytes. Enzyme-linked immunosorbent assay was used to detect the levels of inflammatory factors and pain factors in serum.
Compared with the control group, the levels of interleukin and tumor necrosis factor-α in the model group were significantly increased(P<0.01). Compared with the model group, the levels of interleukin and tumor necrosis factor-α in trigonelline group were significantly decreased(P<0.05). Compared with the control group, the levels of neuropeptide Y and serotonin in the model group increased significantly(P<0.01). Compared with model group, the levels of neuropeptide Y and 5-hydroxytryptamine in fenugreek group were significantly decreased(P<0.05), and high dose fenugreek group was significantly better than low dose group(P<0.05). Compared with the control group, the expression levels of Iba-1 and GFAP in model group were significantly up-regulated(P<0.01). Compared with model group, the expressions of Iba-1 and GFAP in trigonelline group were significantly decreased(P<0.05) in a dose-dependent manner(P<0.05). Compared with the control group, the protein expression levels of TLR4 and NLRP3 in model group were significantly increased(P<0.05), while the protein expression levels of TLR4 and NLRP3 in trigonelline group were significantly decreased(P<0.05), and the inhibitory effect of high-dose trigonelline group was more significant(P<0.05).
Trigonelline inhibits radicular pain in LDH rats by modulating TLR4/NLRP3 pathway.
To investigate the effects of Guaxie Xiangdan recipe combined with bisoprolol on total ischemic burden(TIB) and serum resistin level in patients with stable angina pectoris(SAP).
A total of 150 SAP patients admitted to our hospital from June 2021 to June 2023 were randomly grouped into the Western medicine group(n=75, treated with bisoprolol) and the combination group(n=75, treated with Guaxie Xiangdan recipe+bisoprolol). The therapeutic efficacy, cardiac function indicators, TIB, serum resistin levels and occurrence of adverse reactions were compared between the two groups.
The effective rate of the combination group was higher than that of the Western medicine group, and the difference was statistically significant(P<0.05). After treatment, the left ventricular ejection fraction, and early mitral valve diastolic peak blood flow/late mitral valve diastolic peak blood flow increased in both groups compared to before treatment, and the combination group was higher than the Western medicine group(P<0.05). The levels of TIB and serum resistin in both groups decreased compared to before treatment, and the combination group was lower than the Western medicine group(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups(8.00% vs. 14.67%, P>0.05).
Guaixie Xiangdan recipe combined with bisoprolol can effectively improve the cardiac function of SAP patients, reduce the level of TIB and serum resistin, and has good application safety.